Benign lipomatous neoplasm of of intra-abdominal organs

CD2_BENIGN_LIPO_INTRATHO

renal pelvis carcinoma: A carcinoma arising in the renal pelvis. The majority of renal pelvis carcinomas are transitional cell and less frequently squamous cell carcinomas.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D17.5& Cause of death: ICD-10 — D17.5& 2 out of 7 registries used, show all original rules.	106
4. Check minimum number of events None	106
5. Include endpoints None	106
6. Filter based on genotype QC (FinnGen only)	106

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D17
Name in latin: Neoplasma benignum lipomatosum organorum intra-abdominalium

NAME	CD2_BENIGN_LIPO_INTRATHO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D175
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D175
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign lipomatous neoplasm of of intra-abdominal organs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign lipomatous neoplasm of of intra-abdominal organs

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	625	394	228
Only index persons	590	378	212
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	60.98	60.98	60.94
Only index persons	60.09	60.23	59.85

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	106	63	43
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	62.50	60.23	65.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
90: Matched controls
899

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D17.5

ICD-10 Finland

Benign lipomatous neoplasm of intra-abdominal organs

+∞

129.6

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

7.7

8.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018095) Leukocytes [#/volume] in Urine

308

2.63

5.65

4.2

3.6

48.5

57.2

e6/l

0.14

216

(3030467) Casts [#/volume] in Urine by Automated count

245

2.65

5.57

3.2

3.1

1.1

0.5

e6/l

0.39

181

(36304419) Bacteria [Presence] in Urine

231

2.55

5.04

3.5

2.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

150

2.62

4.57

2.8

2.7

0.5

1.1

e6/l

1.91

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

137

2.66

4.50

2.9

2.8

1.7

2.4

e6/l

0.24

(3011397) Hemoglobin [Presence] in Urine by Test strip

191

2.44

4.29

3.3

3.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

350

2.27

4.15

2.4

2.1

105.3

96.1

pmol/l

0.56

174

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

307

2.27

4.13

3.5

3.1

—

(3002582) Erythrocytes [#/volume] in Urine

266

2.29

4.09

3.4

3.2

21.4

307.0

e6/l

0.59

198

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

205

2.33

3.95

2.3

2.1

3.1

3.2

mg/l

0.10

180

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

101

871

4.38

3.75

18.8

14.7

33.6

21.8

mg/l

1.61

692

(3021601) Nitrite [Presence] in Urine by Test strip

420

2.15

3.59

4.9

5.2

0.0

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

423

2.12

3.49

3.2

3.8

0.0

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

424

2.11

3.46

3.3

3.8

0.0

estimate

—

(3023368) Bacteria identified in Blood by Culture

245

2.10

3.22

4.4

4.2

—

(3026782) Osmolality of Urine

164

2.16

2.93

3.1

3.0

524.0

551.6

mosm/kgh2o

0.29

137

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

151

2.16

2.82

1.2

7.5

8.1

u/ml

0.03

(3007853) Bacteria identified in Skin by Aerobe culture

2.36

2.70

1.9

1.6

—

(3022145) Colonoscopy Study observation

2.34

2.64

1.6

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

156

2.08

2.58

1.3

10.1

32.1

iu/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.60

2.30

1.3

1.7

—

(3044889) 12 lead EKG panel

627

1.92

2.28

3.8

4.1

—

(3012516) Albumin [Mass/volume] in Urine

272

1.83

2.25

3.3

3.1

38.6

48.5

mg/l

0.15

175

(3001604) Monocytes [#/volume] in Blood

428

1.78

2.23

5.4

5.2

0.6

e9/l

0.33

378

(3006315) Basophils [#/volume] in Blood

428

1.78

2.23

5.4

5.2

0.0

e9/l

0.14

379

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.74

2.17

6.5

8.1

—

(1616796) Gas panel - Central venous blood

4.17

2.07

1.8

1.3

—

(40758558) Short blood count panel - Blood

218

1.82

2.06

6.4

8.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

409

1.72

1.98

4.4

4.0

—

(3000850) Epithelial cells [#/volume] in Urine

181

1.83

1.90

3.1

2.7

7.8

4.6

e6/l

0.39

159

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2.26

1.86

2.9

3.7

46.3

61.7

ml/min/173m2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

183

1.80

1.83

1.9

1.8

0.7

1.0

mg/l

1.32

153

(3042936) Bacteria identified in Isolate by Culture

128

1.91

1.78

1.7

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

496

1.67

1.76

3.1

2.9

—

(3000494) Fungus identified in Specimen by Culture

106

1.97

1.73

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

579

1.69

1.71

5.3

4.4

—

516.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

282

1.67

1.70

3.0

3.1

1716.9

1144.1

ng/l

0.39

227

(46235355) HIV 1 and 2 tests - Meaningful Use set

107

1.95

1.68

1.6

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

100

917

2.60

1.68

23.2

17.5

79.8

78.1

umol/l

0.19

100

917

(42870588) Differential panel, method unspecified - Blood

292

1.66

1.68

4.8

5.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

293

1.65

3.8

4.0

5.9

8.6

mg/mmol

0.28

174

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

101

1.94

1.61

1.4

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.81

1.61

2.3

1.5

—

(3002032) Base excess in Venous blood by calculation

2.05

1.59

3.5

4.1

0.5

2.6

mmol/l

—

(40768797) Stomach Pathology biopsy report

125

1.85

1.58

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

208

1.69

1.57

2.5

2.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.54

1.57

1.4

2.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

597

1.64

1.56

5.1

4.5

—

(4034850)

2.70

1.54

15.3

18.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.96

1.53

1.0

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.49

1.50

1.4

2.7

—

(3012544) pH of Venous blood

1.99

1.49

3.5

4.1

—

(40768804) Tissue Pathology biopsy report

375

1.57

1.46

2.5

2.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2.83

1.45

1.3

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

283

1.60

1.45

2.8

2.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

776

1.79

1.43

21.9

15.7

37.8

39.8

1.07

556

(3013650) Neutrophils [#/volume] in Blood by Automated count

503

1.56

1.41

8.5

10.5

4.1

e9/l

0.05

445

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

106

1.84

1.40

1.5

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

100

927

2.39

1.40

11.3

10.8

24.5

24.8

u/l

0.10

100

887

(3002256) Pathology report gross observation

114

1.81

1.40

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.25

1.38

1.2

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.25

1.38

2.6

3.1

23.3

24.9

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.97

1.37

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

209

1.61

1.30

1.2

1.3

—

(40761511) CBC panel - Blood by Automated count

911

2.00

1.14

16.1

14.0

—

(3021589) Normoblasts [#/volume] in Blood

392

1.46

1.11

9.4

10.5

0.0

e9/l

0.52

323

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.45

1.10

1.0

1.2

—

(3000991) Gas panel - Venous blood

1.89

1.10

7.2

8.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.79

1.07

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.86

1.05

4.5

2.4

65.1

66.8

g/l

0.40

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1.86

1.05

6.1

4.3

86.7

86.0

ng/l

0.01

(3019309) Folate [Moles/volume] in Red Blood Cells

184

1.55

1.05

1.5

1.7

1147.5

1184.1

nmol/l

0.07

146

(3014007) Fractional oxyhemoglobin in Arterial blood

1.87

0.99

7.1

9.3

94.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.01

0.99

1.7

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.72

0.96

2.9

2.0

288.7

378.6

nmol/l

0.80

(3049717) Cytology report of Urine Cyto stain

2.29

0.95

1.5

2.6

—

(3047181) Lactate [Moles/volume] in Blood

2.29

0.95

3.3

5.2

1.3

1.1

mmol/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

154

1.54

0.93

1.5

1.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.87

0.91

2.6

3.0

118.2

129.1

g/l

—

(3008898) HLA-B27 [Presence]

2.13

0.91

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

112

0.51

0.89

6.0

4.8

39.7

32.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.06

0.88

1.5

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.99

0.86

1.5

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.99

0.86

1.5

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.80

0.84

2.4

2.3

—

(3016502) Oxygen saturation in Arterial blood

1.64

0.83

6.4

7.8

95.6

96.1

0.23

(3052851) Hemolysis interference index of Serum or Plasma

1.93

0.83

5.3

3.9

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.76

0.83

3.4

3.8

53.6

43.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.71

0.71

1.4

2.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1.63

0.66

2.3

3.8

10.4

253.4

u/ml

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

842

1.46

0.65

17.4

14.3

75.4

77.1

ml/min/173m2

0.31

677

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.76

0.64

2.0

3.8

29.8

32.3

mg/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.76

0.64

1.8

3.8

38.6

52.8

mg/l

—

(3032080) INR in Blood by Coagulation assay

363

1.31

0.63

7.5

8.4

1.4

1.3

inr

0.27

114

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

363

1.31

0.63

5.0

3.8

36.9

36.5

ng/l

0.01

264

(4035726)

0.53

0.58

1.4

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

125

1.43

0.58

20.6

25.7

—

1.3

—

(3026008) Bacteria identified in Urine by Culture

272

1.31

0.57

4.5

3.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1.55

0.56

3.8

8.1

24.4

24.9

mmol/l

—

(3000492) Spirometry study

1.54

0.56

1.3

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

190

1.34

0.54

1.1

1.2

0.5

0.8

u/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.59

0.50

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.59

0.50

2.9

2.5

0.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.59

0.50

8.1

5.3

25.3

24.8

mmol/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.52

0.48

1.9

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.52

0.48

2.9

2.5

0.8

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.52

0.48

1.4

1.7

—

(4010399)

1.48

0.47

1.3

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.41

0.0

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

3.9

—

106.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.40

0.0

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.40

0.0

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.41

0.38

1.0

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

124

0.70

0.37

1.2

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

842

1.27

0.34

3.9

4.3

1.3

mmol/l

0.15

754

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1.35

0.34

3.0

3.3

3.9

0.2

e6/l

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

565

0.84

0.33

3.1

3.0

51.0

50.3

u/l

0.02

523

(1761868) Lipid panel - Serum or Plasma

321

0.83

0.33

3.6

3.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.32

0.31

1.4

1.8

—

(3019060) Gas panel - Arterial blood

1.27

0.28

3.9

4.1

—

(36660697) Celiac disease serology panel - Serum

1.27

0.26

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.22

0.26

1.4

—

(40761536) Microorganisms panel - Urine sediment

0.72

0.25

3.7

3.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

134

1.23

0.24

1.4

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.33

0.23

3.6

5.8

1.6

—

(40768443) Skin Pathology biopsy report

1.33

0.23

1.6

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

221

1.17

0.23

4.5

4.3

21.8

22.3

0.08

100

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

101

0.78

0.22

4.1

9.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.21

0.0

1.9

—

31.1

—

(4146454)

0.00

0.21

0.0

3.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(4281824)

0.00

0.21

0.0

1.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.9

—

63.2

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

3.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

15.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.4

—

(3000330) Specific gravity of Urine by Test strip

1.29

0.21

2.3

5.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.20

0.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

332

1.13

0.18

3.6

4.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

187

1.15

0.17

5.0

4.2

—

(40761535) Cells panel - Urine sediment

1.15

0.17

2.4

3.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

178

1.15

0.16

1.4

1.5

2.3

3.0

g/l

—

100

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.75

0.16

2.8

1.9

—

(3013512) EKG study

273

0.89

0.15

5.4

4.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.81

0.14

3.6

3.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

115

1.15

0.11

9.8

4.9

1.1

1.0

mmol/l

0.36

103

(3025941) Bacteria identified in Stool by Culture

1.12

0.09

2.2

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

127

1.12

0.08

2.0

1.8

29.8

29.5

0.08

121

(21494755) Public health laboratory ask at order entry panel

1.03

0.08

1.3

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

274

0.93

0.07

1.9

2.0

207.6

212.3

u/l

0.02

256

(3012095) Magnesium [Moles/volume] in Serum or Plasma

158

1.09

0.06

5.7

3.2

0.8

mmol/l

0.05

146

(3041096) Erythrocytes [Presence] in Urine by Automated

237

0.96

0.01

3.3

3.6

—

(3029937) Albumin [Presence] in Urine by Test strip

236

0.97

0.00

3.9

0.0

estimate

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

169

1.01

0.00

3.2

2.9

0.9

0.7

ug/l

—

105

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.92

0.00

2.7

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.94

0.00

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

2.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.0

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.96

0.00

1.2

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

0.0

2.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

15.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

0.89

0.00

4.0

2.9

4.9

5.2

kpa

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

0.0

2.0

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

3.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

7.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

11.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

3.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3017569) Oxygen content in Arterial blood

0.00

0.0

12.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.93

0.00

2.6

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

3.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

23.2

—

1631.5

—

(44806420)

0.00

0.0

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

15.7

—

864.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

0.0

2.6

—

13.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.0

—

(4027681)

0.00

0.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

0.98

0.00

3.6

3.1

2.0

2.3

mmol/l

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.9

—

(3004451) EKG impression Narrative

0.00

0.0

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LIPO_INTRATHO and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LIPO_INTRATHO	1.187 [0.88, 1.6]	0.26
Birth year	0.995 [0.99, 1.0]	0.279

During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 322 females with CD2_BENIGN_LIPO_INTRATHO died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LIPO_INTRATHO.

N-year risk	Females	Males
1	0.124%	No data
5	0.725%	No data
10	1.971%	No data
15	3.655%	No data
20	6.148%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIPO_INTRATHO – Benign lipomatous neoplasm of of intra-abdominal organs

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign lipomatous neoplasm of of intra-abdominal organs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints